- Free delivery over £40
- 100% UK-based pharmacy
- Free support and advice
- We’re rated 4.9 out of 5
Elocon Scalp Lotion reviews
Elocon Scalp Lotion FAQs
Technically, no. Novasone and Elocon are different branded products, but they serve the same purpose, and their components are essentially the same. Novasone is available in Australia, whereas Elocon is available in the UK.
No. Elocon lotion should only be used on the scalp, it is too strong for use on the face.
You will need a prescription to purchase Elocon lotion, as it is a very potent corticosteroid treatment. Consult your doctor to see if Elocon is right for you or go through a short consultation with our Online Doctor, the price includes a free private prescription.
No. Elocon is not recommended for use on children under 2 years old and cannot be provided online for patients under 18 years of age. Consult your doctor for alternative treatment options.
Elocon lotion can cause a reduction in skin colour as a side effect, but it should never be used for that specific reason as it can also damage the skin if used too much on one area.
No. You should not apply Elocon lotion on or around your eyes.
No. If it affects hair growth at all, it stimulates it; one of the possible side effects is excessive hair growth (hypertrichosis), although this is very unlikely.
It can. One of the possible side of effects of Elocon lotion is loss of skin colour. It should absolutely not be used for this purpose, though.
Yes. The expiry date is printed on the pack. The expiry date refers to the last date of that month. Do not use Elocon lotion after it has expired.
Yes. Elocon lotion contains a small amount (0.1% of the total) of mometasone furoate, a corticosteroid used to treat inflammation.
If used very heavily, or for extended periods, Elocon lotion can cause skin thinning. It is designed to be used sparingly and under advisement from a doctor, so be sure to get a treatment plan before you begin using Elocon.
When applied, Elocon’s active ingredient, the corticosteroid mometasone furoate, affects the treated skin in the following ways:
- It adjusts protein activity, slowing the activation of those that cause inflammation and hastening the secretion of those that reduce it.
- It works to stabilize the weakened cell membranes.
- It reduces the production of inflammatory cells.
The net result is that the inflammation in the treated skin is reduced and the strength of the skin is bolstered, allowing it to more quickly heal to its normal state.
Elocon is generally considered slightly more potent than Betnovate, requiring fewer applications. It also achieves a higher patient satisfaction score. That said, trials have found that the two treatments have reasonably similar levels of efficacy if used appropriately.
It depends on the case - normally it is not worth the risk. If you are pregnant and interested in using Elocon, consult your doctor to find out if it is a viable option for you.
Clobetasol propionate, the active ingredient in Dermovate, is stronger than mometasone furoate, the active ingredient in Elocon, but it constitutes just 0.05% of the whole, as opposed to 0.1% for mometasone furoate. As a result, the two treatments tend to prove similarly effective, with Elocon meriting a higher patient satisfaction score on the whole.
Elocon lotion is manufactured in Belgium by Schering-Plough Labo NV and marketed by Merck Sharp & Dohme Limited.